XNYSNUS
Market cap309mUSD
Jan 10, Last price
6.22USD
1D
-6.47%
1Q
-0.80%
Jan 2017
-86.98%
Name
NU Skin Enterprises Inc
Chart & Performance
Profile
Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 1,969,131 -11.53% | 2,225,659 -17.44% | |||||||
Cost of revenue | 1,923,673 | 2,089,618 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 45,458 | 136,041 | |||||||
NOPBT Margin | 2.31% | 6.11% | |||||||
Operating Taxes | 17,983 | (15,808) | |||||||
Tax Rate | 39.56% | ||||||||
NOPAT | 27,475 | 151,849 | |||||||
Net income | 8,595 -91.80% | 104,778 -28.85% | |||||||
Dividends | (77,622) | (77,015) | |||||||
Dividend yield | 8.02% | 3.62% | |||||||
Proceeds from repurchase of equity | (13,011) | (70,045) | |||||||
BB yield | 1.34% | 3.29% | |||||||
Debt | |||||||||
Debt current | 48,898 | 25,000 | |||||||
Long-term debt | 662,722 | 530,546 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | 97,192 | 74,454 | |||||||
Net debt | 403,696 | 237,544 | |||||||
Cash flow | |||||||||
Cash from operating activities | 118,639 | 108,062 | |||||||
CAPEX | (58,490) | (59,056) | |||||||
Cash from investing activities | (134,501) | (67,079) | |||||||
Cash from financing activities | 10,730 | (99,504) | |||||||
FCF | 20,311 | 131,782 | |||||||
Balance | |||||||||
Cash | 267,816 | 278,509 | |||||||
Long term investments | 40,108 | 39,493 | |||||||
Excess cash | 209,467 | 206,719 | |||||||
Stockholders' equity | 1,770,555 | 1,853,079 | |||||||
Invested Capital | 1,317,023 | 1,222,215 | |||||||
ROIC | 2.16% | 12.68% | |||||||
ROCE | 2.98% | 9.29% | |||||||
EV | |||||||||
Common stock shares outstanding | 49,860 | 50,525 | |||||||
Price | 19.42 -53.94% | 42.16 -16.93% | |||||||
Market cap | 968,281 -54.54% | 2,130,134 -18.38% | |||||||
EV | 1,371,977 | 2,367,678 | |||||||
EBITDA | 116,381 | 208,547 | |||||||
EV/EBITDA | 11.79 | 11.35 | |||||||
Interest | 21,877 | ||||||||
Interest/NOPBT | 16.08% |